...
首页> 外文期刊>Analytical chemistry >Three-Dimensional Paper-Based Microfluidic Device for Assays of Protein and Glucose in Urine
【24h】

Three-Dimensional Paper-Based Microfluidic Device for Assays of Protein and Glucose in Urine

机译:三维纸基微流控装置用于尿液中蛋白质和葡萄糖的测定

获取原文
获取原文并翻译 | 示例
           

摘要

The first step in curing a disease is being able to detect the disease effectively. Paper-based microfluidic devices are biodegradable and can make diagnosing diseases cost-effective and easy in almost all environments. We created a three-dimesnional (3D) paper device using wax printing fabrication technique and basic principles of origami. This design allows for a versatile fabrication technique over previously reported patterning of SU-8 photoresist on chromatography paper by employing a readily available wax printer. The design also utilizes multiple colorimetric assays that can accommodate one or more analytes including urine, blood, and saliva. In this case to demonstrate the functionality of the 3D paper-based microfluidic system, a urinalysis of protein and glucose assays is conducted. The amounts of glucose and protein introduced to the device are found to be proportional to the color change of each assay. This color change was quantified by use of Adobe Photoshop. Urine samples from participants with no pre-existing health conditions and one person with diabetes were collected and compared against synthetic urine samples with predetermined glucose and protein levels. Utilizing this method, we were able to confirm that both protein and glucose levels were in fact within healthy ranges for healthy participants. For the participant with diabetes, glucose was found to be above the healthy range while the protein level was in the healthy range.
机译:治愈疾病的第一步是能够有效地检测出疾病。纸基微流控设备是可生物降解的,可以在几乎所有环境中经济高效地诊断疾病。我们使用蜡印刷制造技术和折纸的基本原理创建了一个3维(3D)纸设备。通过采用现成的蜡印机,这种设计允许采用一种通用的制造技术,以取代以前报道的在色谱纸上的SU-8光致抗蚀剂的图案。该设计还利用了多个比色测定法,可以容纳一种或多种分析物,包括尿液,血液和唾液。在这种情况下,为演示基于3D纸的微流控系统的功能,对蛋白质和葡萄糖进行了尿液分析。发现引入设备的葡萄糖和蛋白质的量与每种测定的颜色变化成比例。通过使用Adobe Photoshop对这种颜色变化进行了量化。收集没有健康状况的参与者和一名糖尿病患者的尿液样本,并将其与具有预定葡萄糖和蛋白质水平的合成尿液样本进行比较。使用这种方法,我们能够确认蛋白质和葡萄糖水平实际上都在健康参与者的健康范围内。对于患有糖尿病的参与者,发现葡萄糖高于健康范围,而蛋白质水平处于健康范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号